CHRS
#3586
Coherus Oncology, Inc. - Common Stock
1.3 9 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.11%
Monthly Change
-4.79%
6 month change
-17.26%
Year Change
-13.66%
Previous Close
1.4 2
Open
1.3 9
Low
1.3 8
High
1.4 0
Volume
75
Financials
- Market Capitalization 214.76 M
- Employee 144
- Founded 2010
- CEO Dennis Lanfear
- Website www.coherus.com
- Headquarter Delaware, United States
- FIGI BBG0063N8V69
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.34
Price to sales ratio
3.58
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3581 |  NBP NovaBridge Biosciences - American Depositary Shares | 1.89 USD | -5.50% | -2.07% | +6.78% | -58.09% | 218.07 M USD | ||
| 3582 |  SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 76.80 USD | -1.20% | -7.48% | -6.75% | +241.64% | 213.98 M USD | ||
| 3588 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 12.42 USD | -1.04% | -1.90% | +24.32% | -17.26% | 213.02 M USD | ||
| 3592 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 5.62 USD | -3.27% | -1.92% | +13.31% | +384.48% | 212.08 M USD |
Frequently asked questions about Coherus Oncology, Inc. Common Stock
What is the Coherus Oncology, Inc. Common Stock stock price today?
The current price of Coherus Oncology, Inc. Common Stock (CHRS) is 1.3900000000000001. Over the past 24 hours, the stock has changed by -2.11%. Follow the CHRS chart for real-time price dynamics.
What is the stock ticker of Coherus Oncology, Inc. Common Stock?
Coherus Oncology, Inc. Common Stock trades under the ticker CHRS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Coherus Oncology, Inc. Common Stock stock going up?
CHRS has changed by +21.93% over the last week, -4.79% over the last month, and -13.66% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Coherus Oncology, Inc. Common Stock?
Coherus Oncology, Inc. Common Stock currently has a market capitalization of 214.76 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Coherus Oncology, Inc. Common Stock earnings last quarter?
Last quarter, Coherus Oncology, Inc. Common Stock reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Coherus Oncology, Inc. Common Stock revenue for the last quarter?
Coherus Oncology, Inc. Common Stock reported quarterly revenue of 14.31 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Coherus Oncology, Inc. Common Stock net income for the last quarter?
Coherus Oncology, Inc. Common Stock reported net income of -20.63 M for the last quarter. The previous quarter showed -38.33 M, which means net income changed by +46.17%.
How many employees does Coherus Oncology, Inc. Common Stock have?
As of the latest available data, Coherus Oncology, Inc. Common Stock has 144 employees. Workforce size can provide additional context about the company's scale and operations.
What is Coherus Oncology, Inc. Common Stock EBITDA?
Coherus Oncology, Inc. Common Stock EBITDA is -31.73 M, and its EBITDA margin is -221.79%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Coherus Oncology, Inc. Common Stock stock?
You can buy Coherus Oncology, Inc. Common Stock (CHRS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Coherus Oncology, Inc. Common Stock stock?
Investing in Coherus Oncology, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CHRS chart and related analysis on metatrader.com as part of your research.